Admission to Trading

Santander UK Plc

30 July 2026

 

SANTANDER UK PLC*
€35 BILLION GLOBAL COVERED BOND PROGRAMME
Admission to trading of Transferable Securities - Series 88 Tranche 2

The following covered bonds issued by Santander UK plc (the Issuer) have today (30 July 2026) been admitted to trading on the main market of the London Stock Exchange plc:

·           Series 88 Tranche 2 €400,000,000 Fixed Rate Covered Bonds due May 2031 (XS3454380760) (the Series 88 Tranche 2 Covered Bonds) to be consolidated, become fungible and form a single series with the existing Series 88 Tranche 1 €1,000,000,000 Fixed Rate Covered Bonds due May 2031 (XS2823118018) issued and admitted to trading on 20 May 2024.

The Series 88 Tranche 2 Covered Bonds are issued under the Issuer's €35 billion Global Covered Bond Programme (the Programme) pursuant to a prospectus dated 17 March 2026 as supplemented on 1 May 2026, 8 May 2026, 5 June 2026 and 22 July 2026 (the Prospectus), read together with the Final Terms dated 29 July 2026 relating to the Series 88 Tranche 2 Covered Bonds (the Final Terms). Full information on the Issuer and the offer of the Series 88 Tranche 2 Covered Bonds is only available on the basis of the Prospectus, read together with the Final Terms.

The Prospectus and the Final Terms have been published on the website of the London Stock Exchange through a regulatory service (www.londonstockexchange.com) and will also be available on the website of the Issuer at https://www.santander.co.uk/about-santander/investor-relations/santander-uk-covered-bonds.

For further information, please contact:

Funding, Asset Rotation and Investor Relations
Santander UK plc
2 Triton Square
Regent's Place
London NW1 3AN

Email: [e-mail]

* LEI: PTCQB104N23FMNK2RZ28

This announcement replaces RNS Number: 6048O

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries only (as further specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus and the Final Terms is not addressed. Prior to relying on the information contained in the Prospectus and the Final Terms you must ascertain from the Prospectus and the Final Terms whether or not you are part of the intended addressees of the information contained therein. Your right to access this service is conditional upon complying with the above requirement.

 

END